News 16 min read

Cambridge Point at Alewife Is an Approval, Not New Supply

Cambridge approved 2,300 homes at Alewife on September 15. Phase one has no date, the back half is lease blocked to 2040, and the bridge comes last.

The number everybody repeated last week was 2,300. The number I went looking for was a date.

On Tuesday, September 15, 2026, the Cambridge Planning Board approved Cambridge Point, Healthpeak’s 4.6 million square foot master plan for 46 acres of the Alewife Quadrangle, right up against the Belmont line. It is the largest thing approved in Cambridge in a very long time. More than 2,300 homes. Roughly 20 buildings. A pedestrian bridge over the commuter rail tracks to the Alewife Red Line station. A price tag around $4.5 billion.

Then I read the file. There is no completion date in it. Not a soft one, not a target, not a range. The Cambridge and Somerville Independent, which covered the hearing, put it plainly: dates are left unclear in the developer’s materials and in its responses to the board.

There is exactly one hard year printed anywhere in the application. It is 2040. And it does not belong to a construction schedule. It belongs to a lease.

That is the whole story of this approval, and it is the part that got lost. I have watched buyers in North Cambridge, Belmont and Arlington read a headline like this one and quietly decide to wait. My honest advice is that they should not. A zoning vote and a home you can move into are separated here by a gap measured in years, and the thing setting the calendar is not the city.

What the board actually voted on

The vote was docket PB-410, heard in the Sullivan Chamber, and you can see it on the city’s own Planning Board meeting calendar. Worth flagging, because a lot of coverage has the date wrong: several outlets have been citing September 17, which is when Banker & Tradesman published, not when the board voted. The board meets on Tuesdays. September 17 was a Thursday.

What passed is a planned unit development master plan. In plain terms, the city agreed on the shape of a future neighborhood: where the buildings go, how tall they get, where the streets and open space land. Healthpeak assembled these parcels five years ago, originally as a life science play, and the review stalled while Cambridge imposed a moratorium on new lab development and rewrote the Quadrangle’s zoning.

Here is the line from the hearing that nobody put in a headline. Banker & Tradesman reported it in one sentence: the developer still needs to return to the Planning Board for approval of individual buildings.

So on September 15, Cambridge approved a plan for roughly 20 buildings and permitted none of them. Every single one comes back for its own hearing. That is not a criticism of the process, it is just what a master plan is. But it means the distance between last Tuesday and a framed wall is longer than the coverage suggested.

CAMBRIDGE POINT
The headline vs. the record
What was reported What the approval file says
2,300+ homes approved Phase one is 1,000+ homes. The rest follows across three later phases.
A $4.5 billion project is a go Zero buildings are permitted. Each returns to the board separately.
A new bridge to Alewife station Construction starts when 50% of the commercial space is complete.
Housing relief near Alewife It also adds 2.6M SF of office and lab into a 39.5% vacant submarket.
Completion timeline No completion date in the developer’s materials. One hard year: 2040.
Sources: Cambridge Planning Board PB-410, Banker & Tradesman (9/17/26), Cambridge & Somerville Independent (9/16/26), Lincoln Property Co. Q2 2026 Lab Report.

The year 2040, and why it is in a lease

Buried in the application documents is the detail that reframes everything. Four buildings make up the majority of the second phase development sites. All four are encumbered by existing leases that prevent construction until 2040.

The tenant is RTX BBN Technologies, a Raytheon subsidiary that does military research. They are not a squatter and they are not a holdout. They signed a long lease, they are using the space, and their lease outlasts most of the people who voted on this plan.

This is the part I want buyers to sit with. A zoning approval is dated the day it happens. A lease is dated years out. When the two disagree about the calendar, the lease wins every time, because one is a contract and the other is only a permission. Cambridge decided what can eventually be built on those parcels. RTX BBN’s lease decided when. No amount of zoning reform, state housing policy or planning board enthusiasm moves a privately negotiated lease expiration.

So when you read “2,300 homes,” the honest translation is: about 1,000 homes on an unstated schedule, then a long pause, then the balance sometime after a 2040 lease rolls off. The sequencing is deliberate and the developer has been candid about the logic. Homes go first, so that a weak lab market has time to recover and produce tenants for the commercial buildings that follow.

The 2.6 million square feet nobody is asking for

Here is what bothers me most about this project, and it has nothing to do with the housing.

Cambridge Point pairs those 2,300 homes with 2.6 million square feet of new office and lab space, plus 76,000 square feet of retail. It is being dropped into West Cambridge, which according to Lincoln Property Company’s Q2 2026 lab report finished the quarter at 39.5% vacancy. For contrast, East Cambridge came in at 13.4% and Mid Cambridge at 15.5%.

Think about what that spread means. Kendall Square works. The far side of Fresh Pond does not, at least not right now. Nearly four in ten square feet of lab space in this exact submarket is sitting empty, and the plan is to add 2.6 million more.

I want to be fair to the counterargument, because there is a real one. Cambridge just posted its first positive quarter in nine. The market absorbed 78,870 square feet on net in Q2 2026, leasing crossed 1 million square feet, and LPC’s read is that the sector may be starting a gradual path toward stabilization. That is genuinely good news after two brutal years.

But size it honestly. Most of that million square feet was a single transaction, Sanofi extending 900,000 square feet it already occupied. A renewal is not new demand, it is an existing tenant staying put. And at Q2’s net absorption pace, the new commercial space in this one project alone represents about 33 quarters of absorption.

THE ABSORPTION MATH
How long 2.6M SF takes at Cambridge’s current pace
Each tick is one quarter at Q2 2026’s net absorption rate of 78,870 SF.
Q2 2026 net absorption, all of Cambridge
78,870 SF. The first positive quarter in nine.
New commercial space at Cambridge Point
2,600,000 SF of office and lab.
At that pace it is roughly 33 quarters, or about 8 years of region-wide absorption, to fill this project’s new commercial space. That assumes every square foot Cambridge absorbs goes here, and that the 39.5% already vacant stays empty.
Illustrative pace comparison, not a forecast. Source: Lincoln Property Co., Q2 2026 Boston/Cambridge lab report.

One more detail that tells you where this submarket is. The notable West Cambridge lab deal of the quarter was Inari Medical taking 35,000 square feet at 20 Acorn Park Drive, roughly half a mile from the Cambridge Point site. It was a sublease, picking up space somebody else could not use.

This is why the bridge comes last

The pedestrian and bike bridge is the single most valuable thing in this plan for anyone who already lives near Alewife. It is 14 feet wide, well lit, and it would run north to south over the east to west commuter rail tracks. Healthpeak says it could cut walking time to the Alewife Red Line station nearly in half. For the Cambridge Highlands, that is the difference between being next to a subway station and being across a rail corridor from one.

Now connect it to the paragraph above. The zoning requires bridge construction to begin when 50 percent of the commercial portion of the project is complete. Half of 2.6 million square feet. In a submarket at 39.5% vacancy.

The most useful public benefit in the package is gated behind the least wanted private product. That is the structural problem with this approval, and it is not a drafting accident. Healthpeak’s own explanation at the preliminary hearing in May was that it needs large commercial buildings underway in order to fold the bridge’s cost into that construction.

The MBTA piece adds more fog. Healthpeak’s attorney James Rafferty told the board the T had come back with other priorities. His words: “We winced a little bit when we read that.” General Manager Phillip Eng’s letter commits the MBTA to study the corridor and report back to the Planning Board in no later than three years, including a look at “urban rail,” a faster and more frequent service on the inner commuter rail lines. A study that reports in three years is not a station, and a station is not a schedule.

In the meantime, Healthpeak has committed to a shuttle to Alewife running every eight minutes at peak and every 15 to 20 minutes off peak. Note what that concedes. The shuttle exists because the bridge will not be there for a long time.

The affordable units sit on an ordinance that is in court

Cambridge requires developments of 10 or more units to make 20 percent of residential floor area permanently affordable. The ordinance dates to 1998 and was amended to its current 20 percent in 2017. Applied to this project, that is somewhere around 460 income restricted homes, and it is the number that makes the affordability case for Cambridge Point.

Two developers are currently trying to void that rule.

ACTIVE LITIGATION
Two suits against the 20% requirement
Columbia St. LLC
Filed in Land Court, December 2025. First challenge to the ordinance. Still pending. The Massachusetts Attorney General’s office intervened in February 2026 to defend the city, citing consequences for affordable housing policy statewide.
OND 1740 Investors LLC
Filed in Middlesex Superior Court on August 27, 2026, by an affiliate of Old North Development. Target is 1740 Massachusetts Avenue in Porter Square, a six story, 61,300 SF building with 71 apartments and 14 required affordable units. Judge Sarah Ellis denied the developer’s request to force issuance of a building permit, but allowed the case to proceed.
Sources: Cambridge Day (9/4/26), The Harvard Crimson (9/9/26).

The legal theory in both is the same. These developers argue that when a project already complies with zoning as of right, the city cannot condition a building permit on permanently surrendering a fifth of the floor area without compensation. Cambridge and the Attorney General say the requirement is a legitimate exercise of zoning power.

I am not predicting an outcome, and neither should you. What I will say is that the 460 affordable homes inside Cambridge Point are not a fixed quantity. They are the output of a formula that is being litigated on two fronts, and the second case was filed eighteen days before the project was approved.

There is a small detail here I find hard to ignore. Look back at that Planning Board calendar and you will find 1740 Massachusetts Avenue appearing before the same board for advisory consultations in February and again in May of this year. The same body that approved a 2,300 home plan built on the 20 percent rule spent part of its spring hearing from the developer now suing to strike it down.

What actually got built near Alewife during those five years

This is the part I ran myself, because I think it settles the argument better than any press release.

I pulled MLS PIN closing data for Cambridge, Belmont and Arlington covering the twelve months ending September 21, 2026. Residential and small multifamily, closed sales only. That is 1,384 homes that actually changed hands, with real buyers and recorded deeds.

Of those 1,384 sales, 125 were homes built in 2021 or later. Nine percent. In the entire five year stretch that Cambridge Point spent in permitting, new construction made up less than a tenth of what traded across all three towns.

But the split is the interesting part.

BMN BOSTON PROPRIETARY · MLS PIN
Newly built homes as a share of what actually sold
Closed sales, September 15, 2025 through September 21, 2026. Share built in 2021 or later.
Arlington · 77 of 452 sales
17.0%
Cambridge · 40 of 735 sales
5.4%
Belmont · 8 of 197 sales
4.1%
Arlington has no megaproject and no master plan. It delivered nearly twice as many newly built homes into the resale market as Cambridge, off less than two thirds the sales volume.
Source: MLS PIN closed sales, queried directly September 21, 2026. Residential and residential income property types.

Arlington did that with small, boring, unglamorous projects. Look at the 2026 vintage closings and you see pairs: 144 and 146 Webster Street, 35 and 37 Summer Street, 27 Mott Street, 46 Mystic Lake Drive. Two unit condo buildings on single lots. Nobody wrote a $4.5 billion headline about any of them, and no planning board spent five years on them.

Cambridge, with all its institutional capacity and development pressure, put 40 newly built homes into the closed market. Belmont put 8. Zoom into the Alewife ZIP codes and it holds: 02140, which contains Alewife station itself, saw 126 sales with 14 of them newly built. Belmont’s 02478 saw 197 sales with 8 newly built.

The supply that shows up in Greater Boston is almost never the supply that gets announced. It arrives two units at a time, from builders nobody interviews.

Belmont has a more immediate reason to pay attention

If you live in Belmont, the housing timeline is the least relevant part of this. The traffic is not.

Healthpeak’s own projections, as laid out by the Belmont Citizens Forum, put Cambridge Point at roughly 15,000 vehicle trips per day at full build out, with 1,500 to 1,600 trips in the peak hour. Today, the count east of Blanchard Road at the Belmont and Cambridge border runs about 17,780 vehicles daily. The project would add roughly 84 percent on top of that.

And there is no relief valve. All traffic in the Quadrangle ultimately flows to or from Concord Avenue. There is no second route.

Scale matters here too. Belmont has been debating its Hill’s Crossing Overlay District, which would allow up to six stories and 62.5 feet along Brighton Street. Across the line, Cambridge Point’s residential buildings are planned at 7 to 14 stories, 86 to 155 feet. The town is arguing about a building type that Cambridge is about to more than double, a few hundred yards away.

The plan does contemplate a second pedestrian and bike bridge from the site toward Brighton Street in Belmont. On Tuesday the architect David Manfredi said the design accommodates it and that there has been a lot of conversation with the city about it. Accommodating a future bridge and building one are different commitments, and only the first one happened.

What the market near Alewife actually looks like this fall

Set the megaproject aside and look at what a buyer is walking into right now. Same MLS PIN pull, live inventory as of today.

BMN BOSTON PROPRIETARY · MLS PIN
The three towns around Alewife, today
Town Closed, 12 mo. Median price Median days Active now
Cambridge 735 $1,225,000 65 210
Belmont 197 $1,400,000 55 58
Arlington 452 $1,105,000 51 66
All three 1,384 n/a n/a 334
MLS PIN, queried September 21, 2026. Combined months of supply: 2.9.

Three hundred thirty four homes for sale across three towns. Under three months of supply, which is a seller’s market by any standard definition. Arlington is the tightest at about 1.8 months, and its median days on market of 51 tells you buyers there are not getting time to think.

For perspective on the project’s eventual scale, 2,300 homes is about 1.7 times everything that sold in all three towns over a full year. That is genuinely enormous, and I do not want to undersell it. If Cambridge Point fully delivers, it changes this market. The question was never whether it is big. The question is when, and the file does not answer that.

What I would actually do

Four situations, four different answers.

If you are buying near Alewife now. Buy on today’s market, not on the announcement. Do not pay a premium for a bridge whose construction start is tied to leasing 1.3 million square feet of lab space in a 39.5% vacant submarket. If a listing agent works the project into the pitch, ask which phase the site sits near and what the 2040 lease covers. Most will not know.

If you already own in the Highlands, Belmont’s east side, or North Cambridge. Your real exposure is construction, not competition. Decades of staged building on 46 acres, with all of it funneling to Concord Avenue. If you were already planning to sell within a few years, the approval is a mild positive for your story and traffic is the risk to watch. You are not about to be undercut by 2,300 units, because they are not coming at once and most are not coming soon.

If you are renting and waiting for prices to break. Nothing in this vote helps you in 2027 or 2028. Phase one alone is undated. If your plan depends on new supply arriving, you are betting on a schedule the developer declined to put in writing.

If you are an investor watching Cambridge lab. Read the West Cambridge and East Cambridge numbers as two separate markets, because they are behaving like it. A 26 point vacancy gap inside one city is not noise.

The instinct to read a zoning approval as supply relief is understandable and it is wrong. Permission has never been the binding constraint in Greater Boston. Capital, construction cost, lease terms and time are. Cambridge spent five years granting permission on 46 acres. Arlington, in the same stretch, quietly delivered more new homes into its resale market by letting people build two at a time.

If you want a read on what your own place is worth in this market, our home value tool is a reasonable starting point, and you can see live inventory on our Cambridge, Belmont and Arlington pages. If you are trying to decide whether to buy near Alewife this fall or wait it out, reach out. I would rather talk you through the actual timeline than have you plan around a headline.

Sources